Meeting of the Uniform Formulary Beneficiary Advisory Panel, 68566 [06-9391]

Download as PDF sroberts on PROD1PC70 with NOTICES 68566 Federal Register / Vol. 71, No. 227 / Monday, November 27, 2006 / Notices agency’s estimate of burden of the proposed information collection; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the information collection on respondents, including through the use of automated collection techniques or other forms of information technology. DATES: Consideration will be given to all comments received by January 26, 2007. ADDRESSES: You may submit comments, identified by docket number and title, by any of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • Mail: Federal Docket Management System Office, 1160 Defense Pentagon, Washington, DC 20301–1160. Instructions: All submissions received must include the agency name, docket number and title for this Federal Register document. The general policy for comments and other submissions from members of the public is to make these submissions available for public viewing on the Internet at https:// www.regulations.gov as they are received without change, including any personal identifiers or contact information. FOR FURTHER INFORMATION CONTACT: To request more information on this proposed information collection or to obtain a copy of the proposal and associated collection instruments, please write to the Office of the Under Secretary of Defense (Personnel and Readiness) (Program Integration) (Legal Policy), ATTN: LTC Mark J. Gingras, 4000 Defense Pentagon, Washington, DC 20301–4000, or call at (703) 697–3387; facsimile (703) 693–6708. Title, Associated Form, and OMB Control Number: Involuntary Allotment Application; DD Form 2653, OMB Control Number 0704–0367. Needs and Uses: This information collection requirement is necessary to initiate an involuntary allotment from the pay of a member of the Uniformed Services for indebtedness owed a third party under 5 U.S.C. 5520a. 5 U.S.C. 5520a authorizes involuntary allotments if there is a final court judgment acknowledging the debt and it is determined by competent military or executive authority to be in compliance with the procedural requirements of the Soldiers’ and Sailors’ Civil Relief Act. In order to satisfy these statutory requirements, the DD Form 2653, requires the respondent to provide identifying information on the member of the Uniformed Services; provide a certified copy of the judgment, and certify, if applicable, that the judgment VerDate Aug<31>2005 18:21 Nov 24, 2006 Jkt 211001 complies with the Soldiers’ and Sailors’ Civil Relief Act. Affected Public: Individuals or households; businesses or other for profit. Annual Burden Hours: 3,766. Number of Respondents: 7,531. Responses Per Respondent: 1. Average Burden Per Response: 30 minutes. Frequency: On Occasion. SUPPLEMENTARY INFORMATION: Summary of Information Collection This information is used by the Department of Defense to initiate an involuntary allotment from the pay of a member of the Uniformed Services for indebtedness owed a third party as determined by the final judgment of a court. This requirement was created by ‘‘The Hatch Act Reform amendments of 1993,’’ Public Law 103–94. The DD Form 2653, ‘‘Involuntary Allotment Application,’’ requires the creditor to provide identifying information on the member of the Uniformed Services,’ provide a certified copy of the judgment, and certify that the members’ rights under the soldiers’ and Sailors’ Civil Relief Act were protected. Dated: November 17, 2006. Patricia L. Toppings, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 06–9399 Filed 11–24–06; 8:45 am] BILLING CODE 5001–06–M DEPARTMENT OF DEFENSE Office of the Secretary Meeting of the Uniform Formulary Beneficiary Advisory Panel Department of Defense, Assistant Secretary of Defense (Health Affairs). ACTION: Notice of Meeting. AGENCY: This notice announces a meeting of the Uniform Formulary Beneficiary Advisory Panel. The panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics Committee regarding the Uniform Formulary. The meeting will be open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly. Notice of this meeting is required under the Federal Advisory Committee Act. DATES: Wednesday, December 20, 2006, from 8 a.m. to 4 p.m. SUMMARY: PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Major Travis Watson, TRICARE Management Activity, Pharmaceutical Operations Directorate, Beneficiary Advisory Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone 703–681–2890, fax 703–681– 1940 or e-mail at baprequests@tma.osd.mil. SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory Panel will only review and comment on the development of the Uniform Formulary as reflected in the recommendations of the DOD Pharmacy and Therapeutics (P&T) Committee coming out of that body’s meeting in November 2006. The P&T Committee information and subject matter concerning drug classes reviewed for that meeting are available at https:// pec.ha.osd.mil. Any private citizen is permitted to file a written statement with the advisory panel. Statements must be submitted electronically to baprequests@tma.osd.mil no later than December 13, 2006. Any private citizen is permitted to speak at the Beneficiary Advisory Panel meeting, time permitting. One hour will be reserved for public comments, and speaking times will be assigned only to the first twelve citizens to sign up at the meeting, on a first-come, first-served basis. The amount of time allocated to a speaker will not exceed five minutes. ADDRESSES: Dated: November 20, 2006. L.M. Bynum, Alternate OSD Federal Register Liaison Officer, DoD. [FR Doc. 06–9391 Filed 11–24–06; 8:45 am] BILLING CODE 5001–06–M DEPARTMENT OF DEFENSE Department of the Air Force [No. USAF–2006–0010] Submission for OMB Review; Comment Request ACTION: Notice. The Department of Defense has submitted to OMB for clearance, the following proposal for collection of information under the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35). DATES: Consideration will be given to all comments received by December 27, 2006. Title and OMB Number: AFRL/ AFOSR Summer Faculty Fellowship E:\FR\FM\27NON1.SGM 27NON1

Agencies

[Federal Register Volume 71, Number 227 (Monday, November 27, 2006)]
[Notices]
[Page 68566]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9391]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Uniform Formulary 
Beneficiary Advisory Panel. The panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee regarding the Uniform 
Formulary. The meeting will be open to the public. Seating is limited 
and will be provided only to the first 220 people signing in. All 
persons must sign in legibly. Notice of this meeting is required under 
the Federal Advisory Committee Act.

DATES: Wednesday, December 20, 2006, from 8 a.m. to 4 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Major Travis Watson, TRICARE 
Management Activity, Pharmaceutical Operations Directorate, Beneficiary 
Advisory Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, 
telephone 703-681-2890, fax 703-681-1940 or e-mail at 
baprequests@tma.osd.mil.

SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory 
Panel will only review and comment on the development of the Uniform 
Formulary as reflected in the recommendations of the DOD Pharmacy and 
Therapeutics (P&T) Committee coming out of that body's meeting in 
November 2006. The P&T Committee information and subject matter 
concerning drug classes reviewed for that meeting are available at 
https://pec.ha.osd.mil. Any private citizen is permitted to file a 
written statement with the advisory panel. Statements must be submitted 
electronically to baprequests@tma.osd.mil no later than December 13, 
2006. Any private citizen is permitted to speak at the Beneficiary 
Advisory Panel meeting, time permitting. One hour will be reserved for 
public comments, and speaking times will be assigned only to the first 
twelve citizens to sign up at the meeting, on a first-come, first-
served basis. The amount of time allocated to a speaker will not exceed 
five minutes.

    Dated: November 20, 2006.
L.M. Bynum,
Alternate OSD Federal Register Liaison Officer, DoD.
[FR Doc. 06-9391 Filed 11-24-06; 8:45 am]
BILLING CODE 5001-06-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.